aflibercept

Following a strategic collaboration, option and license agreement Ocular Therapeutix Inc (NASDAQ: OCUL) announced with Regeneron Pharmaceuticals Inc (NASDAQ: REGN), BTIG said the deal provides external validation for the former's platform technology. The deduction is based on the fact that...

There is a strong demand for Ocular Therapeutix Inc (NASDAQ: OCUL) shares in the pre-market trading after the company revealed a tactical collaboration, option and license deal with Regeneron Pharmaceuticals Inc (NASDAQ: REGN). Ocular stock surged more than 25 percent. According to the agreement...

Ophthotech Corp (NASDAQ: OPHT), a biopharmaceutical company that develops therapeutics for the treatment of eye diseases, saw its shares fall more than 13 percent Friday. The decline is attributed to an announcement by Regeneron Pharmaceuticals Inc (NASDAQ: REGN), a larger biopharmaceutical...